Entities / Company
Lineage Cell Therapeutics.
biotechnology company
- Reports this week
- 0
- Active events
- 0
- Connections
- 12
What's happening
Gone quiet
No new reports in 90+ days-
The CTS 2025 event took place in Las Vegas, involving Lineage Cell Therapeutics.Speculative1 report
-
Lineage Cell Therapeutics made a company announcement from Carlsbad, with Robert W. Baird & Co. hosting a presentation on September 2, 2025.Some support3 reports1 development inside
-
William Demant Invest provided investment for Lineage Cell Therapeutics' preclinical development on August 26, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Lineage Cell Therapeutics this week
News at the entities that move Lineage Cell Therapeutics most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Lineage Cell Therapeutics
-
Hoffmann-La Roche OperationalNvidia and Hoffmann-La Roche share interest in AI-driven therapeutics following the establishment of a new innovation center in Boston.Moves Lineage Cell Therapeutics
Connections
The 3 strongest of 12, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Hoffmann-La Roche Operational
Hoffmann-La Roche and Lineage Cell Therapeutics maintain an exclusive worldwide collaboration for the development and optimization of the OpRegen therapy.
-
Brian Culley Structural
Brian Culley holds a leadership role that drives the company's strategy focused on cell therapies.
-
FDA Structural
The FDA has cleared necessary materials for Lineage Cell Therapeutics' OpRegen clinical trial.
History
Events by the month they beganJune 2026
3 events- The CTS 2025 event took place in Las Vegas, involving Lineage Cell Therapeutics.
- Lineage Cell Therapeutics made a company announcement from Carlsbad, with Robert W. Baird & Co. hosting a presentation on September 2, 2025.
- William Demant Invest provided investment for Lineage Cell Therapeutics' preclinical development on August 26, 2025.